Xcelerate
Xcelerate (OTCMKTS: XCRT) is a publicly traded company that controls AfiyaSasa Africa LLC, an AI/AR-enabled mobile healthcare platform targeting underserved African markets, currently in clinical validation with a Tanzania pilot and first patient onboarding targeted for Q3 2026.
- Company typePublic
- Founded1996
- HeadquartersCoral Springs, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Xcelerate does
Xcelerate (OTCMKTS: XCRT) is a publicly traded company founded in 1996 and headquartered in Coral Springs, Florida. It holds a 51% controlling interest in AfiyaSasa Africa LLC, an AI- and AR-supported healthcare platform designed to connect patients and physicians via mobile devices in underserved markets, with its first pilot program in Tanzania.
The platform's core technology is delivered through a partnership with AdviNOW Medical and combines artificial intelligence with augmented reality to enable remote patient–physician interaction on mobile endpoints. Xcelerate has begun assembling supporting capabilities around this core, including a Chief Science Officer (Dr. Anja Glisovic), a consulting agreement with a Tanzanian physician (Dr. Desire Ruhinda) for clinical onboarding, and a small IP portfolio of 2 granted patents and 2 pending applications.
The business model is pre-commercial: Xcelerate has no publicly disclosed revenue, has just entered clinical validation (with first clinical patient onboarding targeted for Q3 2026), and is refocusing its capital base after divesting its interest in ESN Group in December 2025. The company employs between 11 and 50 people and serves healthcare providers and patients in emerging markets, principally Sub-Saharan Africa, via its consolidated subsidiary.
Xcelerate firmographics
Firmographics- Name
- Xcelerate
- Legal name
- Xcelerate, Inc.
- Website
- https://xcelerate.global
- Company type
- Public
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Xcelerate (OTCMKTS: XCRT) is a publicly traded company that controls AfiyaSasa Africa LLC, an AI/AR-enabled mobile healthcare platform targeting underserved African markets, currently in clinical validation with a Tanzania pilot and first patient onboarding targeted for Q3 2026.
- Ownership category
- akta.pro rank
Xcelerate industry classification
Industry- Product category
- Digital Health Platform
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Software Publishers (5132), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)
- akta.pro secondary industries
- Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO), Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps) (HLAHAIAM)
Keywords
Where Xcelerate is headquartered
LocationHeadquarters
- HQ city
- Coral Springs
- HQ country
- United States
- HQ region
- North America
Markets served
Xcelerate business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Healthcare Technology Solutions: Revenue generated through development and deployment of AI-assisted healthcare projects, including potential licensing of medical technology platforms and associated services in underserved healthcare markets.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Xcelerate product offering
Product offeringCore offering
Xcelerate develops and deploys an AI and AR-enabled clinical platform that connects patients and physicians via mobile devices to extend healthcare access in underserved African markets. The platform, originally developed by AdviNOW Medical, is operated through its majority-owned subsidiary AfiyaSasa Africa LLC (51% interest) and is currently being clinically validated in Tanzania, with first patient onboarding anticipated in Q3 2026. The company also holds an IP portfolio covering wound treatment methods, viral infection methods, and pending surgical tools with targeting guidance.
Product overview
Xcelerate operates as a healthcare technology company with a portfolio focused on AI-assisted medical solutions. The primary offering is the AfiyaSasa Africa Platform, a medical technology and virtual health system that uses AI and AR to connect patients and physicians via mobile devices. This platform was developed by AdviNOW and is being deployed through an AI-supported clinical platform in Tanzania. The company also maintains intellectual property related to wound treatment, viral infection methods, and surgical tools with targeting guidance. Xcelerate sold its interest in ESN Group to strengthen its financial position and is pursuing digital engagement initiatives alongside its core healthcare AI projects.
Differentiator
Problem solved
Functional benefit
Products and services
- AfiyaSasa Africa Platform An AI and AR-enabled medical technology and virtual health platform that connects patients and physicians via mobile devices for clinical consultations. Developed by AdviNOW Medical and majority-owned (51%) by Xcelerate through subsidiary AfiyaSasa Africa LLC, it is targeted at extending healthcare access in underserved African markets. It is currently being clinically validated in Tanzania with first patient onboarding anticipated in Q3 2026.
Quantifiable outcome
- First clinical patient onboarding anticipated Q3 2026
Companies that use Xcelerate
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Xcelerate technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature2 records
Xcelerate partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Local Technical Partners (Tanzania)coreLocal technical partners in Tanzania supporting the AfiyaSasa Africa healthcare program deployment, working with Xcelerate and AdviNOW Medical on system integration and clinical validation.
- Local Clinical Partners (Tanzania)coreLocal clinical partners in Tanzania coordinating with Xcelerate for the AfiyaSasa Africa healthcare program, transitioning from system integration to initial clinical validation.
- Dr. Desire RuhindacoreTanzanian medical doctor engaged under consulting agreement to support AfiyaSasa Africa initiative by reviewing AdviNOW Medical system capabilities, identifying localization requirements aligned with Tanzanian treatment guidelines, and identifying clinical sites for potential pilot program.
- AdviNOW MedicalcoreAdviNOW developed the AI and AR platform for AfiyaSasa Africa, a start-up specializing in medical technology and virtual health. Xcelerate acquired 51% interest in AfiyaSasa Africa, which uses this platform to extend healthcare access in Africa.
Scale indicators4 records
Recent moves7 records
Expansion highlights3 records
Xcelerate competitors and assessment
Company assessmentDirect peers
- K Health: K Health delivers AI-first virtual primary care via a mobile platform that connects patients with physicians using AI-supported triage and clinical decisioning — directly analogous to Xcelerate's AI/AR physician-connection model, though focused on US payors.
- 98point6: 98point6 is a text-based, AI-augmented virtual care platform connecting patients with physicians via mobile devices. Mirrors Xcelerate's mobile, AI-supported clinical workflow architecture in a more mature US commercial setting.
- Forward (Forward Health): Forward is a tech-enabled primary care company combining AI-driven clinical workflows with physician consultations delivered through connected hardware and mobile apps — comparable technology stack and care-delivery thesis to Xcelerate's AI/AR clinical platform.
- AdviNOW Medical: AdviNOW is Xcelerate's core technology partner and developed the AI/AR platform deployed through AfiyaSasa Africa. Operates in the same AI-enabled clinical workflow and virtual care space, serving as both collaborator and adjacent competitor for physician-shortage markets.
Emerging players
- Helium Health: Helium Health provides electronic medical records and telehealth solutions to hospitals and clinics across West Africa. Targets the same underserved African healthcare delivery market where Xcelerate is deploying its platform.
- Zipline: Zipline operates autonomous drone-based medical delivery in several African countries, addressing healthcare access gaps in underserved markets. While the modality differs, the focus on extending healthcare into infrastructure-constrained African geographies is highly comparable to Xcelerate's Tanzania focus.
Broad incumbents
- Doctor On Demand (Included Health): Doctor On Demand, now part of Included Health, delivers virtual physician visits via mobile. While broader in scope, its direct-to-patient virtual care model overlaps with Xcelerate's mobile-first patient-to-physician connection thesis.
- Amwell (American Well): Amwell is a leading enterprise telehealth platform connecting patients and clinicians across health systems and payers. Its broader portfolio of virtual care offerings provides a scaled incumbent benchmark for Xcelerate's mobile telehealth play.
- Teladoc Health: Teladoc is the largest publicly-listed telehealth incumbent, offering virtual physician consultations across multiple specialties and geographies. Serves as the established scaled comparable for the virtual-care category Xcelerate is entering.
Regional players
- mPharma: mPharma operates a healthcare supply-chain and pharmacy-tech platform across multiple African markets. While focused on pharmaceutical distribution rather than virtual care, its pan-African healthcare footprint provides a regional comparison for market entry and scaling across underserved geographies.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat2 records
Key highlights6 records
Customer concentration
Xcelerate social profiles
Digital presenceXcelerate financial estimates
Financial estimateRevenue estimate
Valuation estimate
Xcelerate leadership team
Management profileNumber of profiles
Profiles1 record
Xcelerate subsidiaries and ownership
Company hierarchySubsidiaries1 record
Xcelerate funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Xcelerate M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Xcelerate
What does Xcelerate do?
Xcelerate develops and deploys an AI and AR-enabled clinical platform that connects patients and physicians via mobile devices to extend healthcare access in underserved African markets. The platform, originally developed by AdviNOW Medical, is operated through its majority-owned subsidiary AfiyaSasa Africa LLC (51% interest) and is currently being clinically validated in Tanzania, with first patient onboarding anticipated in Q3 2026. The company also holds an IP portfolio covering wound treatment methods, viral infection methods, and pending surgical tools with targeting guidance.
Is Xcelerate a public or private company?
Xcelerate is a public company. It is classified as public and is currently operating.
When was Xcelerate founded?
Xcelerate was founded in 1996. It employs 1 to 10 people.
Where is Xcelerate based?
Xcelerate is headquartered in Coral Springs, United States, in the North America region.
How does Xcelerate make money?
One revenue line is on record: healthcare Technology Solutions.
Who are Xcelerate's main competitors?
Direct peers on record are K Health, 98point6, Forward (Forward Health) and AdviNOW Medical. Emerging players are Helium Health and Zipline. Broad incumbents are Doctor On Demand (Included Health), Amwell (American Well) and Teladoc Health. mPharma is listed as a regional player.
Does Xcelerate have an API?
No public API is recorded for Xcelerate.
What industry is Xcelerate in?
Xcelerate's product category is Digital Health Platform. Its primary akta.pro industry code is HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring, with a secondary code of HLACAFAO, Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways). Its NAICS code is 334510 and its SIC code is 3845.